Y. Ying

Strategies to compare clinical antitherapeutic antibody data when changing assay platforms: a case study.

V. Quarmby, S. Fischer, Sock-Cheng Lewin-Koh, 2015, Bioanalysis.

A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.

A. Rahman, Michael Fox, V. Quarmby, 2010, Journal of immunological methods.

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

T. Singer, D. Danilenko, F. Theil, 2012, mAbs.

THE EFFECTS OF SODIUM NITROPRUSSIDE AND L-GLUTAMATE ON THE REGULATION OF THE CYTOSKELETAL ASSOCIATED PROTEIN TAU IN PRIMARY CULTURED NEURONS FROM RAT

F. Murad, J. Chen, H. Ghanbari, 1995 .

Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease

G. Kerchner, K. Scearce-Levie, I. Hötzel, 2021, Science Translational Medicine.

Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities

V. Quarmby, M. Vanderlaan, Shan Chung, 2012, mAbs.

Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics*

L. Khawli, R. Kelley, S. Prabhu, 2015, The Journal of Biological Chemistry.

A novel immunoassay to measure total serum lymphotoxin-α levels in the presence of an anti-LTα therapeutic antibody.

J. Grogan, A. Nguyen, A. Chuntharapai, 2015, Journal of immunological methods.